1. Home
  2. ULCC vs NBTX Comparison

ULCC vs NBTX Comparison

Compare ULCC & NBTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Frontier Group Holdings Inc.

ULCC

Frontier Group Holdings Inc.

HOLD

Current Price

$5.60

Market Cap

1.1B

ML Signal

HOLD

Logo Nanobiotix S.A.

NBTX

Nanobiotix S.A.

HOLD

Current Price

$21.00

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ULCC
NBTX
Founded
1994
2003
Country
United States
France
Employees
N/A
N/A
Industry
Air Freight/Delivery Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
1.0B
IPO Year
2021
2020

Fundamental Metrics

Financial Performance
Metric
ULCC
NBTX
Price
$5.60
$21.00
Analyst Decision
Hold
Strong Buy
Analyst Count
10
1
Target Price
$5.56
$8.00
AVG Volume (30 Days)
4.0M
52.5K
Earning Date
11-05-2025
09-30-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$3,729,000,000.00
$11,930,711.00
Revenue This Year
$0.37
N/A
Revenue Next Year
$14.59
$136.64
P/E Ratio
N/A
N/A
Revenue Growth
1.77
N/A
52 Week Low
$2.89
$2.76
52 Week High
$10.26
$30.35

Technical Indicators

Market Signals
Indicator
ULCC
NBTX
Relative Strength Index (RSI) 79.97 52.34
Support Level $4.71 $20.05
Resistance Level $4.60 $22.05
Average True Range (ATR) 0.28 0.92
MACD 0.17 -0.01
Stochastic Oscillator 99.75 65.23

Price Performance

Historical Comparison
ULCC
NBTX

About ULCC Frontier Group Holdings Inc.

Frontier Group Holdings Inc is an ultra-low-cost carrier whose business is focused on Low Fares Done Right. The company owns a fleet of 120 Airbus single-aisle aircraft, consisting of 13 A320ceos, 82 A320neos, 21 A321ceos and 4 A321neos. The use of these aircraft, their seating configuration, weight-saving tactics, and baggage process have all contributed to the ability to continue to be the fuel-efficient of all the U.S. The Company is managed as a single business unit that provides air transportation for passengers. Majority of revenue is from Domestic flight follow by International.

About NBTX Nanobiotix S.A.

Nanobiotix SA is a clinical-stage biotechnology company that has one operating segment, which focuses on developing product candidates that use its proprietary nanotechnology to transform cancer treatment by increasing the efficacy of radiotherapy. The company develops NanoXray products to help patients receiving radiotherapy by magnifying the effect of radiotherapy within tumor cells without increasing the dose to surrounding healthy tissues. Its product candidate is NBTXR3, a preclinical research program for cancer immunotherapies.

Share on Social Networks: